Wellnex Life Ltd (ASX:WNX, AIM:WNX) has entered early-stage due diligence following unsolicited approaches for the potential acquisition of its Pain Away brand and other assets, as the health and wellness group explores a range of financing options to support its turnaround strategy.
The company said it had also received an indicative proposal from a syndicate offering convertible note funding to expand the Pain Away brand into Asian and North American markets, in line with its goal of achieving positive free cash flow and long-term profitability.
Discussions are at a preliminary stage and form part of a broader review of financing solutions, which also includes traditional debt and equity alternatives.
In an update, the company said it is assessing the various proposals to determine the optimal capital structure to maximise shareholder value and fund upcoming obligations, including the repayment of loans to former directors due in April 2026.
Wellnex recently reported a significant improvement in first-half earnings before interest, tax, depreciation and amortisation, and gross margin, stating its turnaround plan remains on track.
The company said any transaction would be subject to applicable regulatory approvals and cautioned that there was no certainty that any of the approaches would proceed or on what terms.